Breast Neoplasms: all 12,820 studies

Page 30 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning StudyRecruitingNCT01284153
• Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer PatientsAvailableNCT01216124
• Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After LumpectomyRecruitingNCT01185132Phase 3
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerRecruitingNCT01174121Phase 2
• Cardiotoxicity of Cancer Therapy (CCT)Enrolling by invitationNCT01173341
• Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruitingNCT01042548
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingNCT01042379Phase 2
• Magnetic Resonance Imaging of Breast CancerRecruitingNCT01035112Not applicable
• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruitingNCT01034033
• Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruitingNCT01000883
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
• Collecting and Storing Tissue Samples From Women With or Without Breast CancerRecruitingNCT00899301
• Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast CancerRecruitingNCT00898131
• Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruitingNCT00823654
• Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsRecruitingNCT00722228Phase 1/2
• Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruitingNCT00451022
• A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast CancerRecruitingNCT00438074
• Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.RecruitingNCT00437879
• Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer CellsRecruitingNCT00353483
• High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerRecruitingNCT00291096
• Breast Cancer in Pregnancy Register StudyRecruitingNCT00196833
• Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT00068003
• Collection of Blood From Patients With CancerRecruitingNCT00034216
• A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult VolunteersCompletedNCT07300202Phase 1Results posted
• Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast CancerCompletedNCT07216274Not applicableResults posted
• Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer SurvivorsCompletedNCT07160439Not applicableResults posted
• Trial to Evaluate the Impact of Various Interventions to Increase the Uptake of Surveillance Mammography in Eligible Women in SingaporeCompletedNCT06733155Not applicableResults posted
• A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post MenopauseCompletedNCT06465368Phase 2Results posted
• CairnSurgical Breast Cancer Locator (BCL) Post-Market StudyCompletedNCT06461663Not applicableResults posted
• A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.CompletedNCT06307457Results posted
• Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer PatientsCompletedNCT06243796Not applicableResults posted
• A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Active, not recruitingNCT06206837Phase 1/2Results posted
• An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition InformationCompletedNCT06193070Not applicableResults posted
• PECS II vs. MTP for Analgesia After MRMCompletedNCT06187909Not applicableResults posted
• Increasing Screening for Cancer Using EHR-NudgesCompletedNCT06177795Not applicableResults posted
• Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer SurvivorsTerminatedNCT06162663Phase 4Results posted
• Promoting Resilience in Women With Breast CancerCompletedNCT06133348Not applicableResults posted
• Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.CompletedNCT06086340Results posted
• Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid TumorCompletedNCT06048367Phase 1Results posted
• TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast CancerActive, not recruitingNCT06001762Phase 2Results posted
• A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast CancerTerminatedNCT05966584Phase 2Results posted
• Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT05954143Phase 2Results posted
• Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial ToxicityCompletedNCT05871125Not applicableResults posted
• ICG and SLN MappingCompletedNCT05859971Early Phase 1Results posted
• Music Therapy as a Tool for Anxiety Reduction in Localized Breast CancerCompletedNCT05856656Not applicableResults posted
• Promoting Informed Choice for Breast Cancer Screening: A Longitudinal StudyCompletedNCT05838417Not applicableResults posted
• Impact of Topical Tranexamic Acid in Breast ReconstructionTerminatedNCT05807074Phase 4Results posted
• Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense BreastsCompletedNCT05787249Not applicableResults posted
• A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.CompletedNCT05770713Results posted
• Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer DetectionCompletedNCT05757427Not applicableResults posted
• Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+PertuzumabTerminatedNCT05744375Phase 2Results posted
• Assessing the Time Demands of CancerActive, not recruitingNCT05708703Results posted
• Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%CompletedNCT05659563Phase 2Results posted
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerActive, not recruitingNCT05654623Phase 3Results posted
• Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast CancerTerminatedNCT05618613Phase 1/2Results posted
• A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With NeratinibCompletedNCT05599334Results posted
• Wrist Cooling for Hot Flashes Clinical TrialCompletedNCT05595213Not applicableResults posted
• A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerCompletedNCT05584644Results posted
• Computerized Cognitive Training in Breast Cancer SurvivorsCompletedNCT05570604Not applicableResults posted
• Diabetes Care for Breast Cancer PatientsCompletedNCT05565534Not applicableResults posted
• Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast CancerActive, not recruitingNCT05558722Phase 2Results posted
• A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryCompletedNCT05549505Phase 2Results posted
• Intervention to Promote Breast Cancer Screening Among American Indian WomenCompletedNCT05530603Not applicableResults posted
• Evaluation of a Cone-beam CT Scanner for Image Guided RadiotherapyCompletedNCT05524454Not applicableResults posted
• Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerCompletedNCT05498155Phase 2Results posted
• Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer SurvivorsCompletedNCT05473026Not applicableResults posted
• Culturally Aware AET Non-Initiation InterventionCompletedNCT05465408Not applicableResults posted
• A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)Active, not recruitingNCT05463952Phase 1Results posted
• A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During SurgeryTerminatedNCT05457842Phase 2Results posted
• A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in DenmarkCompletedNCT05452798Results posted
• Alcohol and Breast Cancer (ABC) TrialCompletedNCT05423730Not applicableResults posted
• A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast CancerCompletedNCT05415215Phase 3Results posted
• Behavioural Science Messages in Breast Cancer ScreeningCompletedNCT05395871Not applicableResults posted
• Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast CancerTerminatedNCT05384119Phase 1Results posted
• Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-LactCompletedNCT05376527Phase 1Results posted
• Promoting Informed Choice for Breast Cancer ScreeningCompletedNCT05376241Phase 2Results posted
• Real-World Effectiveness of Palbociclib in Combination With an Aromatase InhibitorCompletedNCT05361655Results posted
• Study Assessing QBS72S For Treating Brain MetastasesActive, not recruitingNCT05305365Phase 2Results posted
• Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.CompletedNCT05303129Not applicableResults posted
• Interest of Virtual Reality on Anxiety Before the Planning CT Scan in RadiotherapyCompletedNCT05269186Not applicableResults posted
• Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)TerminatedNCT05269160Phase 1/2Results posted
• Project Breast47: Effect of an Educational InterventionCompletedNCT05267171Not applicableResults posted
• Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)CompletedNCT05259696Phase 1/2Results posted
• A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast CancerCompletedNCT05258747Phase 1Results posted
• Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis TestTerminatedNCT05243641Phase 1/2Results posted
• mHealth for Breast Cancer Survivors With InsomniaCompletedNCT05233800Not applicableResults posted
• A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic CancerActive, not recruitingNCT05215769Not applicableResults posted
• A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast CancerActive, not recruitingNCT05203445Phase 2Results posted
• A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast CancerCompletedNCT05190770Phase 2Results posted
• Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisCompletedNCT05185947Phase 2Results posted
• Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision RadiotherapyCompletedNCT05176860Not applicableResults posted
• Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerActive, not recruitingNCT05169567Phase 3Results posted
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsTerminatedNCT05169437Phase 2Results posted
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• Breathwork App for Cancer SurvivorsCompletedNCT05161260Not applicableResults posted
• Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.CompletedNCT05155566Results posted
• Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in JapanCompletedNCT05153187Results posted
• Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2mCompletedNCT05141708Results posted
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive, not recruitingNCT05132582Phase 3Results posted
• Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related ToxicityTerminatedNCT05128773Phase 3Results posted

← Breast Neoplasms overview